GlassScriptPhysician profile
Jeannette Guerrasio
NPI 1083648679
$5,132.46
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $1,204 · 2021: $2,294 · 2022: $1,175.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $579.61 | 2019-2022 | |
| Abbvie INC. | $556.32 | 2019-2022 | |
| Amgen INC. | $430.54 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $330.24 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $313.00 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $229.20 | 2019-2021 | |
| Lilly USA, LLC | $228.27 | 2019-2022 | |
| Eisai INC. | $207.47 | 2020-2022 | |
| Amarin Pharma, INC. | $190.12 | 2020-2021 | |
| Astellas Pharma US INC | $182.89 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.33 | 2019-2021 | |
| Esperion Therapeutics, INC. | $143.60 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $143.35 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $120.89 | 2020-2021 | |
| Allergan, INC. | $117.49 | 2020-2021 |
Show all 41 companies
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeannette Guerrasio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.